transdermal dihexa-dmso DMSO Gel, 90% DIHEXA | Peptide Synthetic |

Evidence-based: Our content is sourced from reputable U.S.-based healthcare professionals and peer-reviewed research

Legal and Safety Information: UK-Peptides proudly provides BPC-157 strictly for scientific and research use

LL-37 possesses immunomodulatory properties that influence various immune cells, including neutrophils, macrophages, dendritic cells, and lymphocytes (Nagaoka et al., 2001)

This hypothesis remains debated, because reliable detection of the endogenous peptide in vivo faces its low abundance and the analytical difficulty of distinguishing the active fragment from its precursors

Over 26 weeks, including a dose-escalation period of up to 6 weeks, researchers observed mean percentage weight reductions of 6.0% to 10.8% across the cagrilintide dose groups compared to just 3.0% with placebo